Obstacles to Clinical Trial Recruitment
Author Information
Author(s): Reed N, Siddiqui N
Primary Institution: Western Infirmary, Beatson Oncology Centre
Conclusion
The study highlights significant barriers to patient recruitment for clinical trials, particularly in areas of social deprivation and rurality.
Supporting Evidence
- Only 68 out of 106 patients were deemed fit enough for a Platinum/Taxane combination treatment.
- The study achieved a 29% participation rate in clinical trials, above the national average.
- Patients from areas of high social deprivation face unique challenges in accessing clinical trials.
Takeaway
This study shows that many patients who need treatment for ovarian cancer can't join clinical trials because of various challenges, like living far away or not being healthy enough.
Methodology
The study examined patients in the Grampian region over a 3-year period who were referred for treatment of ovarian cancer.
Potential Biases
Potential biases in patient selection and treatment recommendations based on social and geographical factors.
Limitations
The study may not fully represent all populations due to geographical and social factors.
Participant Demographics
Patients from the Grampian region, including those from urban and rural areas, with a median age of 76 years for those receiving carboplatin only.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website